These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28185879)

  • 1. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
    Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
    J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
    Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
    J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
    Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
    Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
    Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
    Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
    Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
    Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
    Mou W; Gao L; He J; Yin J; Xu B; Gui J
    Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
    Barthels C; Puchałka J; Racek T; Klein C; Brocker T
    PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
    Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
    J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration.
    Maina V; Marrella V; Mantero S; Cassani B; Fontana E; Anselmo A; Del Prete A; Sozzani S; Vezzoni P; Poliani PL; Villa A
    J Leukoc Biol; 2013 Dec; 94(6):1221-30. PubMed ID: 24052573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
    Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
    Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable clinical presentation of hypomorphic DCLRE1C deficiency from childhood to adulthood.
    Hazar E; Karaselek MA; Kapakli H; Dogar O; Kuccukturk S; Uygun V; Artac H; Fındık S; Sahin A; Arslan S; Guner S; Reisli I; Keles S
    Pediatr Allergy Immunol; 2024 Oct; 35(10):e14260. PubMed ID: 39425552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
    Nahum A; Somech R; Shubinsky G; Levy J; Broides A
    Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
    Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
    Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omenn syndrome: inflammation in leaky severe combined immunodeficiency.
    Villa A; Notarangelo LD; Roifman CM
    J Allergy Clin Immunol; 2008 Dec; 122(6):1082-6. PubMed ID: 18992930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
    Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
    J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome.
    Rigoni R; Fontana E; Dobbs K; Marrella V; Taverniti V; Maina V; Facoetti A; D'Amico G; Al-Herz W; Cruz-Munoz ME; Schuetz C; Gennery AR; Garabedian EK; Giliani S; Draper D; Dbaibo G; Geha RS; Meyts I; Tousseyn T; Neven B; Moshous D; Fischer A; Schulz A; Finocchi A; Kuhns DB; Fink DL; Lionakis MS; Swamydas M; Guglielmetti S; Alejo J; Myles IA; Pittaluga S; Notarangelo LD; Villa A; Cassani B
    J Allergy Clin Immunol; 2020 Nov; 146(5):1165-1179.e11. PubMed ID: 32311393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.